Abeona Therapeutics (ABEO)
(Delayed Data from NSDQ)
$5.34 USD
-0.05 (-0.93%)
Updated Jul 16, 2024 04:00 PM ET
After-Market: $5.32 -0.02 (-0.37%) 5:28 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
Abeona Therapeutics Inc. [ABEO]
Reports for Purchase
Showing records 61 - 80 ( 87 total )
Company: Abeona Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Pivotal Phase 3 Trial FDA Guidance Received; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Company: Abeona Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
1Q17 Financial Results Reported; Pipeline Continues to Mature; Reiterate Buy
Provider: Rodman & Renshaw, Co.
Company: Abeona Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
1Q17 Financial Results Reported; Pipeline Continues to Mature; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Company: Abeona Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Solid Cash Position; Multiple Clinical-Stage Catalysts; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Company: Abeona Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Solid Cash Position; Multiple Clinical-Stage Catalysts; Reiterate Buy
Provider: Rodman & Renshaw, Co.
Company: Abeona Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Continued Clinical Advancement; Raising Price Target to $20
Provider: H.C. Wainwright & Co., Inc.
Company: Abeona Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Continued Clinical Advancement; Raising Price Target to $20
Provider: Rodman & Renshaw, Co.
Company: Abeona Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Pipeline Progress Accelerating on Multiple Fronts; Reiterate Buy
Provider: Rodman & Renshaw, Co.
Company: Abeona Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Pipeline Progress Accelerating on Multiple Fronts; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Company: Abeona Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Data Safety Monitoring Board Authorizes ABO-102 Dose Escalation; Reiterate Buy
Provider: Rodman & Renshaw, Co.
Company: Abeona Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Data Safety Monitoring Board Authorizes ABO-102 Dose Escalation; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Company: Abeona Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
2Q16 Financial Results Reported; Continuing Clinical Progress; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Company: Abeona Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
2Q16 Financial Results Reported; Continuing Clinical Progress; Reiterate Buy
Provider: Rodman & Renshaw, Co.
Company: Abeona Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
New Collaboration Agreement Announced; Reiterate Buy
Provider: Rodman & Renshaw, Co.
Company: Abeona Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
New Collaboration Agreement Announced; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Company: Abeona Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Abeona Accelerating Progress; Reiterate Buy
Provider: Rodman & Renshaw, Co.
Company: Abeona Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Abeona Accelerating Progress; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Company: Abeona Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Patient Dosing Initiated; 1Q 2016 Financials Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Company: Abeona Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Patient Dosing Initiated; 1Q 2016 Financials Reported; Reiterate Buy
Provider: Rodman & Renshaw, Co.
Company: Abeona Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Transferring Coverage; Reiterating Buy and Instituting $17 Price Target
Provider: H.C. Wainwright & Co., Inc.